Cellular immune responses in autoimmune thyroid disease

被引:152
作者
Weetman, AP [1 ]
机构
[1] Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Sheffield S5 7AU, S Yorkshire, England
关键词
D O I
10.1111/j.1365-2265.2004.02085.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent research in autoimmune thyroid disease (AITD) has largely focused on delineation of the autoantigens and their epitopes, but there is now renewed interest in the immunoregulatory properties of T cells, an understanding of which may explain the emergence of AITD in experimental settings. T cell recognition of autoantigens has shown considerable intra- and interindividual heterogeneity, and a mixed pattern of cytokine production indicates that both the Th1 and Th2 limbs of the helper T cell response are involved in all types of AITD. It is now clear that secretion of chemokines and cytokines within the thyroid accounts for the accumulation and expansion of the intrathyroidal lymphocyte pool, and that the thyroid cells themselves contribute to this secretion. The thyroid cells also produce a number of proinflammatory molecules which will tend to exacerbate the autoimmune process. Thyroid cell destruction in autoimmune hypothyroidism is dependent on T cell-mediated cytotoxicity with the likely additional effect of death receptor-mediated apoptosis.
引用
收藏
页码:405 / 413
页数:9
相关论文
共 75 条
[1]   LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION [J].
ACHAORBEA, H ;
MITCHELL, DJ ;
TIMMERMANN, L ;
WRAITH, DC ;
TAUSCH, GS ;
WALDOR, MK ;
ZAMVIL, SS ;
MCDEVITT, HO ;
STEINMAN, L .
CELL, 1988, 54 (02) :263-273
[2]   Cytokines and thyroid function [J].
Ajjan, RA ;
Watson, PF ;
Weetman, AP .
ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (04) :359-386
[3]   Thyroid autoimmune disease -: Demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers [J].
Armengol, MP ;
Juan, M ;
Lucas-Martín, A ;
Fernández-Figueras, MT ;
Jaraquemada, D ;
Gallart, T ;
Pujol-Borrell, R .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03) :861-873
[4]   Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases [J].
Armengol, MP ;
Cardoso-Schmidt, CB ;
Fernández, M ;
Ferrer, X ;
Pujol-Borrell, R ;
Juan, M .
JOURNAL OF IMMUNOLOGY, 2003, 170 (12) :6320-6328
[5]   Editorial: Dying (apoptosing?) for a consensus on the fas death pathway in the thyroid [J].
Baker, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2593-2595
[6]   Multiparameter precursor analysis of T-cell responses to antigen [J].
Bercovici, N ;
Givan, AL ;
Waugh, MG ;
Fisher, JL ;
Vernel-Pauillac, F ;
Ernstoff, MS ;
Abastado, JP ;
Wallace, PK .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 276 (1-2) :5-17
[7]   Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? [J].
Bretz, JD ;
Baker, JR .
CLINICAL ENDOCRINOLOGY, 2001, 55 (01) :1-11
[8]   Whole-blood proliferation assay for autoimmune thyroid disease: Comparison to density-gradient separated-peripheral blood lymphocytes [J].
Butscher, WG ;
Ladenson, PW ;
Burek, CL .
THYROID, 2001, 11 (06) :531-537
[9]   Long-term outcome of interferon-α-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment [J].
Carella, C ;
Mazziotti, G ;
Morisco, F ;
Manganella, G ;
Rotondi, M ;
Tuccillo, C ;
Sorvillo, F ;
Caporaso, N ;
Amato, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :1925-1929
[10]   Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis [J].
Coles, AJ ;
Wing, N ;
Smith, S ;
Coraddu, F ;
Greer, S ;
Taylor, C ;
Weetman, A ;
Hale, G ;
Chatterjee, VK ;
Waldmann, H ;
Compston, A .
LANCET, 1999, 354 (9191) :1691-1695